e-Drug3D

1886

STIRIPENTOL

INN
STIRIPENTOL

cas 137767-55-6

CLASS

NERVOUS SYSTEM
TREATMENT OF SEIZURES ASSOCIATED WITH DRAVET SYNDROME IN PATIENTS 2 YEARS OF AGE AND OLDER TAKING CLOBAZAM
THE MECHANISM OF ACTION IS UNKNOWN

ROUTE (list)

ORAL

ATC code

N03AX17

PK parameters

Tmax 2.5 HOUR
PPB 99 PERCENT
t1/2 8.7 HOUR

Solubility

PRACTICALLY INSOLUBLE IN WATER

Target

DrugCentral

Unknown

Download SDF file

1-Penten-3-ol, 1-(1,3-benzodioxol-5-yl)-4,4-dimethyl-, (1E)-

Formula:
C14H18O3

Calculated chemical properties:

MW 234.28
NB_atoms 17
XLogP 2.84
PSA 39.951
NB_HD 1
NB_HA 3
fsp3 0.43
Lipinski(0=no;1=yes) 1

FDA
NDA 206709 (label) INN (STIRIPENTOL) DIACOMIT (BIOCODEX SA) APPROVAL= AP YEAR= 2018 NEWMOLECULARENTITY
NDA 207223 (label) INN (STIRIPENTOL) DIACOMIT (BIOCODEX SA) APPROVAL= AP YEAR= 2018